Bone mineral density in egyptian children with juvenile idiopathic arthritis: possible correlation to serum RANKL /

Riham Eid1, Maha Abdelsalam2,3, Aya Ahmed Fathy4

  • 1Paediatric Nephrology Unit, Faculty of Medicine, Mansoura University Children's Hospital, Mansoura University, Mansoura, 35561, Egypt. rihameid@mans.edu.eg.

Insights

Juvenile idiopathic arthritis (JIA) in children is linked to lower bone mineral density (BMD). Specific osteoprotegerin (OPG) gene variants and higher RANKL/OPG ratios are associated with reduced BMD in JIA patients.

Area of Science:

  • Pediatric Rheumatology
  • Bone Metabolism
  • Genetic Epidemiology

Background:

  • Juvenile idiopathic arthritis (JIA) increases children's risk of decreased bone mineral density (BMD).
  • Causes include genetic, disease-related, and medication-related factors.
  • Osteoprotegerin (OPG) and its related factors may influence BMD in JIA.

Purpose of the Study:

  • To investigate the impact of OPG gene polymorphisms on BMD in children with JIA.
  • To assess the association between serum OPG, RANKL levels, and the RANKL/OPG ratio with BMD in JIA.
  • To identify potential determinants of reduced BMD in pediatric arthritis.

Main Methods:

  • Evaluated OPG gene polymorphisms (rs2073617, rs3134069) and serum RANKL, OPG, and RANKL/OPG ratio in 60 JIA children and 100 controls.
  • Measured BMD using dual-energy X-ray absorptiometry (DEXA), classifying patients by z-score.
  • Assessed disease activity with Juvenile Arthritis Disease Activity Score (JADAS) and articular damage with the juvenile arthritis damage index (JADI).

Main Results:

  • No significant differences in genotype or allele frequencies between JIA patients and controls.
  • Serum RANKL and RANKL/OPG ratio were significantly higher in JIA patients.
  • Patients with BMD z-score below -2 showed higher frequencies of rs2073617 TT genotype/T allele, elevated RANKL/OPG ratio, and greater disease damage.

Conclusions:

  • Egyptian children with JIA exhibit decreased BMD.
  • The rs2073617 TT genotype and T allele, along with the RANKL/OPG ratio, are potential determinants of reduced BMD in JIA.
  • Monitoring BMD and controlling disease activity are crucial for preserving bone health in JIA.
Abstract

Related Concept Videos

Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.7K
Hormones and Bone Tissue01:17

Hormones and Bone Tissue

The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.8K
Role of Vitamins in Maintaining Bone Health01:25

Role of Vitamins in Maintaining Bone Health

The growth and maintenance of bone are regulated by a combination of nutritional factors, including vitamins, such as vitamin A, B12, C, D, and K.
Vitamin A
Vitamin A is involved in the process of bone remodeling. Retinoic acid, the active metabolite of Vitamin A, has nuclear receptors in osteoblasts and osteoclasts, which are involved in bone remodeling.
Vitamin B12
Vitamin B12 acts as a cofactor during the formation of osteoblast-related proteins, such as osteocalcin. Vitamin B12 plays a role...
3.5K
Osteoclasts in Bone Remodeling01:31

Osteoclasts in Bone Remodeling

Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
3.0K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
42